leg veins chronic venous disease PAD peripheral artery disease

New guidelines help interventional cardiologists manage chronic venous disease

"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained. 

artificial intelligence AI in healthcare

Women less likely to receive DCD heart transplants

Donation after circulatory death heart transplants are gaining popularity in the United States, but men are much more likely to be selected for one. 

man making a decision

At a crossroads: Surgical heart valve innovation slows as transcatheter treatments keep evolving

Has the success of TAVR and other interventional techniques had a negative impact on surgical valve innovation? Two surgeons shared their concerns in a new commentary. 

Tria Mitral Valve Foldax

Polymer heart valve, the first of its kind to gain commercial approval, linked to positive 1-year data

The new-look mitral valve is built using LifePolymer, a proprietary material that does not include any animal tissue. Both the frame and its leaflets are robotically generated to match each patient’s anatomy.

Thumbnail

Female heart surgeons take home much lower salaries

Both base salaries and total compensation are consistently lower for women than men, according to new survey data. The disparities in cardiac surgery are often worse than those found in other healthcare specialties.

The first Black American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, explains the impact of Trump administration restrictions on diversity equity and inclusion (DEI) on healthcare programs and clinical trials that address women, minority and low-income patients.

How anti-DEI healthcare policies are impacting patient care

All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.

cardiovascular heart diagnostics

Heart attack deaths are way down after decades of breakthroughs—but other risks have skyrocketed

Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.

The Evoque transcatheter tricuspid valve replacement (TTVR) system for tricuspid regurgitation from Edwards Lifesciences

TTVR with Evoque system linked to positive real-world outcomes after 30 days

According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation.